Researchers at Columbia University have been awarded nearly $39 million from ARPA-H to develop a living knee replacement using biomaterials and human stem cells. The project, called NOVAJoint, aims to create a biocompatible, patient-specific knee joint replacement that integrates with the patient's native bone. The researchers plan to complete prototype development within two years and conduct clinical trials within five years.

6m read timeFrom engineering.columbia.edu
Post cover image
Table of contents
The AwardImpact of OsteoarthritisNOVAJoint — a living solution to ravaged kneesThe CollaboratorsEquity and CommercializationThe Research Team

Sort: